You are here: Industry Insights > Biopharmaceutical

News List

Lonza Expands Cell Culture Med Portfolio americanpharmaceuticalreview
July 07, 2020
Lonza has expanded its cell culture media portfolio with the addition of the GSv9™ Media and Feeds, providing a fully integrated solution specifically designed to optimize recombinant protein production using Lonza’s GS Gene Expression System®.
New standards to help remove foreign particles in bioprocessing europeanpharmaceuticalreview
May 05, 2020
ASTM International says its new standard for single use system manufacturing processes will help to prevent the contamination of biopharmaceuticals with foreign particles.
Pressure BioSciences, RedShiftBio Combine Technologies to Enable Development and Production of Biotherapeutics americanpharmaceuticalreview
April 20, 2020
Pressure BioSciences announced the combination of PBI's patented Pressure Cycling Technology (PCT) with RedShiftBio's proprietary Microfluidic Modulation Spectroscopy (MMS) ...
Insilico Opens Subsidiary in Boston contractpharma
March 03, 2020
The Boston subsidiary´s prime location is within the largest biopharmaceutical hub in the US.
Bolt Biotherapeutics Announces Scientific Advisory Board Appointment americanpharmaceuticalreview
January 14, 2020
Bolt Biotherapeutics announced the addition of Priti Hegde, Ph.D., to its scientific advisory board. Dr. Hegde, who currently serves as chief scientific officer at Foundation Medicine ...
First company awarded market authorisation under new Chinese drug law europeanpharmaceuticalreview
January 07, 2020
The mAb tislelizumab has been granted approval from Chinese authorities, making Boehringer Ingelheim Biopharmaceuticals the first MAH under the new system.
Focusing on Cutting-edge Biopharmaceutical Technologies, Boosting the Industry to Achieve Innovation and Development --bioLIVE China 2020 is Ready En-CPhI.CN
December 25, 2019
To seize the ever-changing opportunities in the new era and to meet the ever-growing market demands, the annual gala of the biopharmaceutical industry--- bioLIVE China 2020, will be held again at Hall W4 in the SNIEC on June 22-24, 2020.
Pharma and Biotech Review: Chinese Biopharmaceutical Industry: Key Developments and Growing Trends Neeta Ratanghayra
November 24, 2019
Between 2012 and 2016, China’s biopharma market grew from $9.4 billion to $22.8 billion, and the market is expected to touch $48.8 billion in sales by 2022.1
Innovent to develop & commercialize a novel diabetes medicine in China biospectrumasia
August 22, 2019
Innovent Biologics, Inc., a world-class biopharmaceutical company that develops and commercializes high-quality medicines, has announced that it has entered into a licensing agreement with Eli Lilly and Company (Lilly) for the development and potential co
NIIMBL, FDA Sign New Agreement to Support Biopharmaceutical Manufacturing americanpharmaceuticalreview
August 01, 2019
The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) announced that the University of Delaware, on behalf of NIIMBL, has entered into a Collaborative Research and Development Agreement (CRADA) with the Food and Drug Administr

Previous page 1 2 3 4 5 6 7 Next page